Patient advocacy, support group for Neuroendocrine cancers. Supporting NET Cancer patients and connecting specialists across the Indian subcontinent since 2014
📢Do not miss this year’s @ENETS_ORG & INCA #NETCancerDay Educational Webinar on November 12th, 2025 from 16:00 CET.
👉Join ENETS experts and NET patients to explore carcinoid syndrome, NEC and genetic syndromes.
✅Look at the agenda register for free: incalliance.org/enets-inca-n…#LetsTalkAboutNETs
We’re talking — again — about Neuroendocrine Tumors,
a group of complex cancers that deserve recognition and timely diagnosis.
We reaffirm our commitment at CNETS India— to educate, connect, and advocate
#NETCancerDay#CNETSIndia#MedTwitter#LetsTalkaboutNETs#sorrynotsorry
📢On November 10th, #NETCancerDay, INCA pleads to all NET patients and caregivers as well as HCPs, to take the #SCAN2025 Global Survey and share their insights on NET diagnostics and access to treatments. ✅Add your voice in your language here: incalliance.org/scan2025/#LetsTalkAboutNETs#WeSCAN
#INCASummit2025
INCA Access Committee Chair Dr Sugandha Dureja @sugandhadureja reported on successful #ThinkNENs e-learning used so far by 370 HCPs, mostly GPs, from 71 countries as well as the launch of #SCAN2025 Global Survey gathering insights from NET patients and HCPs to replicate or even exceed the approx. 5000 respondents from 2019.
#LetsTalkAboutNETs
📢One voice matters. Thousands create change! The SCAN 2025 Global Survey is your opportunity to influence how NETs are understood and treated worldwide.
· For NET patients and HCPs
· 15 languages
✅Be a changemaker and take the survey today: incalliance.org/scan2025/#LetsTalkAboutNETs#WeSCAN